Modification of the N-Glycosylation Pathway to Produce Homogeneous, Human-Like Glycans Using GlycoSwitch Plasmids
| Abstract |
|
|
Glycosylation is an important issue in heterologous protein production for therapeutic applications. Glycoproteins produced
in Pichia pastoris contain high mannose glycan structures that can hamper downstream processing, might be immunogenic, and cause rapid clearance
from the circulation. This chapter describes a method that helps solving these glycosylation-related problems by inactivation
of OCH1, overexpression of an HDEL-tagged mannosidase, and overexpression of a Kre2/GlcNAc-transferase I chimeric enzyme. Different
plasmids are described as well as glycan analysis methods.
Affiliation(s): (2) Fundamental and Applied Molecular Biology, Department of Molecular Biomedical Research, Ghent University, Ghent, Belgium
(3) Department of Biology, Zürich, Switzerland
(3) Department of Biology, Zürich, Switzerland
Book Title: Pichia Protocols
Series: Methods in Molecular Biology | Volume: 389 | Pub. Date: Aug-08-2007 | Page Range: 119-138 | DOI: 10.1007/978-1-59745-456-8_9
Subject: Biotechnology
Key Words: Pichia pastoris - glycosylation -
N-glycans - glyco-engineering - GlycoSwitch - OCH1 - α-1,2-mannosidase - GlcNAc-transferase I - DSA-FACE - protein production - glycan analysis
Comments (Loading...) |
||
Loading... |





















